Brief: Island Pharmaceuticals Says Clinical Trial Agreement Signed With Research Foundation For State University Of New York
09/11/2021 01:27
Nov 9 (Reuters) - Island Pharmaceuticals Ltd ILA.AX :
* CLINICAL TRIAL AGREEMENT SIGNED WITH RESEARCH FOUNDATION
FOR
STATE UNIVERSITY OF NEW YORK
Source text for Eikon: ID:nASX6nhRDW
Further company coverage: ILA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Island Pharmaceuticals
See all newsBrief: Island Pharmaceuticals Says Pivotal Marburg Data Secured For Galidesivir FDA Pathway
Brief: Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 Million
Australia's Island Pharmaceuticals rises as company boosts Galidesivir production
Brief: Island Pharmaceuticals Boosts Galidesivir Supply As Ebola Surges
Island Pharmaceuticals hits seven-month high on Galidesivir approval for Ebola epidemic